Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?

Volume: 70, Issue: 3, Pages: 360 - 366
Published: Jul 5, 2010
Abstract
The National Health Service (NHS) should reward innovation it values. This will enable the NHS and the United Kingdom (UK) economy to benefit and impact positively on the Research and Development (R&D) decision making of companies. The National Institute for Health and Clinical Excellence (NICE) currently seeks to do this on behalf of the NHS. Yet the Office of Fair Trading proposals for Value Based Pricing add price setting powers--initially...
Paper Details
Title
Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?
Published Date
Jul 5, 2010
Volume
70
Issue
3
Pages
360 - 366
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.